Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Clopidogrel Bisulphate Related Compound A
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Clopidogrel EP Impurity A is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Clopidogrel EP Impurity A usage and description
Clopidogrel EP Impurity A is a pharmaceutical impurity that is used in the production of the antiplatelet drug, Clopidogrel. The impurity is a by-product of the synthesis of Clopidogrel and is considered to be a minor impurity. The impurity is known to have a molecular mass of 342.32 g/mol and a molecular formula of C16H17ClNO2S.
Clopidogrel EP Impurity A is classified as a thiol-containing compound and is known to have a similar chemical structure to the active ingredient of Clopidogrel. The impurity is believed to have a similar mechanism of action to the active ingredient of Clopidogrel, which is to inhibit the platelet activation and aggregation.
The impurity is typically removed from the final product through various purification techniques, including chromatography and crystallization. The amount of Clopidogrel EP Impurity A present in the final product is typically very low, usually less than 0.1%.
In conclusion, Clopidogrel EP Impurity A is an important component in the synthesis of the antiplatelet drug, Clopidogrel. While it is considered to be a minor impurity, it is still closely monitored and regulated to ensure the safety and efficacy of the final product.
